Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 7, 2014; 20(29): 10094-10107
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.10094
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.10094
Figure 2 PCI-24781 synergizes with the cis-diamminedichloroplatinum-induced gastric cancer cell apoptosis and clonogenic inhibition.
A, B: After appropriate treatment [PCI-24781, cis-diamminedichloroplatinum (CDDP) and combination] for 48 h, the apoptosis of the HGC27 cells was measured using flow cytometry of annexin V labeled cells (A) and the quantum dot analysis of cleaved caspase-3 (B). The number of apoptotic cells was remarkably increased in the PCI-24781- or CDDP-treated groups, with a synergistic effect in the combination treated group; C, D: PCI-24781 or CDDP partially abrogates the colony formation capacity of the GC cells (10 d). The combination treatment exhibited a synergistic effect. Combo: Combination treatment. aP < 0.05 vs the control; cP < 0.05 vs PCI-24781 or CDDP.
-
Citation: He WL, Li YH, Hou WJ, Ke ZF, Chen XL, Lu LY, Cai SR, Song W, Zhang CH, He YL. RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and
cis -diamminedichloroplatinum on gastric cancer. World J Gastroenterol 2014; 20(29): 10094-10107 - URL: https://www.wjgnet.com/1007-9327/full/v20/i29/10094.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i29.10094